PHI with Tuberculous coxitis
How does this condition affect your private health insurance?
Ischiophthisis, or tuberculous coxitis, is a chronic infectious disease primarily affecting the hip joint, caused by Mycobacterium tuberculosis. It typically results from hematogenous spread from a primary lung infection, though the lung focus might be latent. This destructive process involves the articular cartilage, subchondral bone, and synovial membrane, leading to gradual joint erosion, pain, stiffness, muscle atrophy, and eventually deformity. If untreated, it can cause severe disability, joint destruction, abscess formation, and systemic complications. Early diagnosis and aggressive, prolonged anti-tuberculosis therapy are crucial to prevent irreversible damage and preserve joint function.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 25%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
6-18 months for active infection and initial treatment, but symptoms can be insidious for months or years prior to diagnosis.
Duration of Illness (Lifetime)
Chronic, often with lifelong consequences due to permanent joint damage, functional limitations, and potential for recurrence or accelerated osteoarthritis.
Cost of Treatment (Initial)
High, including extensive diagnostics (imaging, biopsy), prolonged multi-drug anti-tuberculosis therapy (6-18 months), potential surgical intervention, and initial physical therapy. Can range from tens of thousands to over a hundred thousand USD.
Cost of Treatment (Lifetime)
High, encompassing long-term physical therapy, assistive devices, management of residual pain and disability, potential further surgeries (e.g., joint replacement), and ongoing monitoring.
Mortality Rate
Low (1-5%) with appropriate modern treatment, but significantly higher if untreated, in immunocompromised individuals, or if severe systemic complications develop.
Risk of Secondary Damages
Very high. Common sequelae include significant joint destruction, deformity, chronic pain, limb shortening, muscle atrophy, joint ankylosis, and severe functional impairment. Psychological impact is also possible.
Probability of Full Recovery
Low. While the infection can be cured, complete recovery without any residual functional deficit or joint damage is rare, especially if diagnosis is delayed. Most individuals experience some degree of permanent limitation.
Underlying Disease Risk
Moderate to high. Often associated with immunocompromised states (e.g., HIV/AIDS, diabetes, malnutrition, long-term corticosteroid use) or a history of close contact with active pulmonary tuberculosis.